Navigation Links
UCI Medical Affiliates, Inc.'s Internal Investigation Leads to SEC Action and Criminal Charges Against Former Executive Officer
Date:7/8/2009

hs to thoroughly investigate this matter and to timely and thoroughly report our findings to the Securities and Exchange Commission and Department of Justice."

Advisory Note Regarding Forward-Looking Statements

Certain of the statements contained in this press release are forward-looking statements subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. We caution readers of this press release that such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to materially differ from our current expectations or any results expressed or implied by such forward-looking statements. Specifically, our statements in this press release regarding the status, preliminary indications and ongoing nature of, and our expectations regarding, the financial statements that we intend to restate or may restate, as well as any estimated amounts and impact of potential adjustments in any restated financial statements are forward-looking statements. Factors that could cause actual results to differ from current expectations include, among other things, additional developments in and findings of the ongoing audit, the possible impact of such developments, factors that may affect the timing of and ability to complete the audit and the time needed for the Company, its counsel and outside auditors to review these matters, any matters arising from the review and preparation of adjustments to our previously issued financial statements and the impact of all such matters on reports filed or to be filed with the Securities and Exchange Commission. These possible impacts include, but are not limited to, the following: damage to our business or reputation; the discovery of items that require additional or greater than expected adjustment to, or restatement of, our historical financial statements; impairment of our ability to prepare and timely file with the Secur
'/>"/>

SOURCE UCI Medical Affiliates, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine news :

1. MDS Nordion Continues to Urge Government of Canada to Complete MAPLE Project to Address Critical Medical Isotope Shortage
2. Forsyth Medical Center participating in Avastin trial for new glioblastoma patients
3. Versus Technology, Inc. Announces Sale of Real-Time Location System to the St. Louis VA Medical Center
4. Insite Security Partners With WorldClinic to Offer Global Medical Support to Clients
5. Hybrid Concierge Medical Practice Provides More Value, Options to Growing Number of Physicians Nationwide
6. Latest Studies Show Junk Drinks Pose as Many Health Threats as Junk Food According to AquaHydrate Medical Advisor
7. TeamHealth Medical Call Center Awarded Third Consecutive URAC Health Call Center Accreditation
8. Medical Data Systems, Inc. (MDS) Announces Operations Expansion and Opening of its Primary Collections Operations Office
9. Council for American Medical Innovation and Hoosiers Work for Health Host Indiana Forum on Medical Innovation
10. Detroit Medical Center to Partner With my1HIE(R) and Link With United Physicians and Olympia Physician Groups
11. iData Research Publishes Market Analysis Series on Electronic Medical Records and PACS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Blacks, other minorities might not gain full benefit from ... -- Human embryonic stem cell lines currently used for ... finds. , That could mean that non-whites will ... that research down the line, experts say. , Blacks ... most widely used stem cell lines studied showed any ...
(Date:12/16/2009)... (Nasdaq: MDRX ) announced today that it ... and six months ended November 30, 2009 before ... 2010. Allscripts management will host a conference call ... other information at 8:30 AM Eastern Standard Time ... ) ,, Allscripts fiscal second quarter earnings will ...
(Date:12/16/2009)... WASHINGTON, Dec. 16 As a result of ... a new peer reviewed cancer research program is included ... ,, This new cancer research program will research ... the breast, prostate, lung and ovarian cancer research programs ... Command. ,, The $15 million in funding ...
(Date:12/16/2009)... that increase susceptibility to disease , , WEDNESDAY, Dec. ... increased susceptibility to leprosy have been identified by ... who analyzed more than 10,000 DNA samples from ... their discovery highlights the important role that the ... leprosy. , "Though leprosy is not common, the ...
(Date:12/16/2009)... health and environmental concerns about the emerging nanotechnology industry, ... behavior of nanoparticles in municipal sewage treatment plants ... published in ACS, journal Environmental Science & Technology ... Ecology and Hydrology and colleagues note that experts predict ... less than 1/1000th the width of a human hair ...
Breaking Medicine News(10 mins):Health News:Most Stem Cells Used in Research Come From Whites 2Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 2Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 3Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 4Health News:House Creates New Cancer Research Program 2Health News:House Creates New Cancer Research Program 3Health News:Leprosy Genes Identified 2Health News:Behavior modification could ease concerns about nanoparticles 2
... Jack Mackenroth to debut signature campaign scarf at ... NEW YORK, Nov. 7 Jack Mackenroth, from ... debuting an HIV and AIDS,education campaign called Living ... Men,s Health Crisis Fashion Forward event. At Fashion ...
... combine efforts to simplify claims and transaction ... Nov. 10 In order,to provide solutions ... for healthcare companies, Axway, recognized leader of ... quality and compliance,solutions have formed a strategic ...
... via Google Earth and,Compatibility with Polar,s Range of ... N.Y., Nov. 10 Polar (http://www.polarusa.com ),the ... technology,today introduced the RS800CX, the most advanced and ... the growing,multisport market., The RS800CX offers athletes ...
... Revenue and Gross Profit Increase, LOVELAND, Colo., ... today reported financial results for its third quarter ... Heska Corporation ("Heska" or the "Company") generated ... an increase of 21% from the,prior year period., ...
... 3 Clinical Trial For Duska,s ATPace In Planning ... Nov. 10 /PRNewswire-FirstCall/,-- Duska Therapeutics, Inc., (OTC Bulletin ... they have entered into a,preliminary agreement to collaborate ... Duska,s planned pivotal Phase 3 clinical trial in,paroxysmal ...
... Montreal Heart Institute Research,Centre Director Dr. ... trial demonstrating that VIA-2291, an investigational drug ... production,of leukotrienes, proposed mediators of vascular inflammation, ... well-tolerated with no serious,adverse events attributed to ...
Other Medicine News:Health News:'Project Runway' Designer Brings Living Positive By Design Campaign to New York to Educate About Living With HIV and Combat Stigma Associated With the Disease 2Health News:'Project Runway' Designer Brings Living Positive By Design Campaign to New York to Educate About Living With HIV and Combat Stigma Associated With the Disease 3Health News:'Project Runway' Designer Brings Living Positive By Design Campaign to New York to Educate About Living With HIV and Combat Stigma Associated With the Disease 4Health News:Axway and Edifecs Form Strategic Partnership to Benefit Healthcare Payors 2Health News:Axway and Edifecs Form Strategic Partnership to Benefit Healthcare Payors 3Health News:Polar Introduces the RS800CX Training Management System for Multisport Endurance Athletes 2Health News:Polar Introduces the RS800CX Training Management System for Multisport Endurance Athletes 3Health News:Polar Introduces the RS800CX Training Management System for Multisport Endurance Athletes 4Health News:Heska Announces Q3 2008 Results 2Health News:Heska Announces Q3 2008 Results 3Health News:Heska Announces Q3 2008 Results 4Health News:Heska Announces Q3 2008 Results 5Health News:Heska Announces Q3 2008 Results 6Health News:Heska Announces Q3 2008 Results 7Health News:Heska Announces Q3 2008 Results 8Health News:Duska Therapeutics and DSM Pharmaceuticals in Manufacturing Collaboration for PSVT Drug Product 2Health News:Duska Therapeutics and DSM Pharmaceuticals in Manufacturing Collaboration for PSVT Drug Product 3Health News:Duska Therapeutics and DSM Pharmaceuticals in Manufacturing Collaboration for PSVT Drug Product 4Health News:Duska Therapeutics and DSM Pharmaceuticals in Manufacturing Collaboration for PSVT Drug Product 5Health News:The Results From a Clinical Trial Led by the Montreal Heart Institute Demonstrate That Drug Reduces Inflammation in Patients With Serious Cardiovascular Disease 2Health News:The Results From a Clinical Trial Led by the Montreal Heart Institute Demonstrate That Drug Reduces Inflammation in Patients With Serious Cardiovascular Disease 3
(Date:12/16/2009)... Ill., Dec. 16 Hospira, Inc. (NYSE: ... medication delivery company, today announced that it will host ... 2009 results and projections for 2010 on Thursday, Feb. ... company will release its fourth-quarter and full-year 2009 results ... and the conference call. ,, A live webcast of ...
(Date:12/16/2009)... International, well-known,scientific experts were ... (80 mg/day),data presented as "extremely promising."[1] ... and clinicians critically reviewed these data.,These ... generic lipid-modifying,treatments, fenofibrate and bezafibrate, in ... in patients with metabolic syndrome,and type ...
(Date:12/16/2009)... -- Verathon®, maker of BladderScan® bladder volume ... bladder volume ultrasound is now included in ... Prevention of Catheter-Associated Urinary Tract Infections (CA-UTIs). ... early November 2009, replace the previous guidelines ... guidelines are located on the Web at: ...
Breaking Medicine Technology:International, Well-Known Scientific Experts Say That New GFT505 Data Unlikely to Have the Potential to Affect the Established Role of Generic Fenofibrate and Bezafibrate in Managing Atherogenic Dyslipidemia 2International, Well-Known Scientific Experts Say That New GFT505 Data Unlikely to Have the Potential to Affect the Established Role of Generic Fenofibrate and Bezafibrate in Managing Atherogenic Dyslipidemia 3New 2009 CDC Guidelines for the Prevention of Catheter-Associated Urinary Tract Infections Include Bladder Volume Ultrasound 2New 2009 CDC Guidelines for the Prevention of Catheter-Associated Urinary Tract Infections Include Bladder Volume Ultrasound 3New 2009 CDC Guidelines for the Prevention of Catheter-Associated Urinary Tract Infections Include Bladder Volume Ultrasound 4New 2009 CDC Guidelines for the Prevention of Catheter-Associated Urinary Tract Infections Include Bladder Volume Ultrasound 5AMICAS Showcases Vendor Neutral Archive Solutions at SIIM 2009 47969 1AMICAS Showcases Vendor Neutral Archive Solutions at SIIM 2009 47969 2AMICAS Showcases Vendor Neutral Archive Solutions at SIIM 2009 47969 3AMICAS Showcases Vendor Neutral Archive Solutions at SIIM 2009 47969 4Mach One Corporation Developing a Nasal Hand Carried Product as Solution to Swine Flu 28H1N1 29 Virus 12476 1Mach One Corporation Developing a Nasal Hand Carried Product as Solution to Swine Flu 28H1N1 29 Virus 12476 2Lifeclinic Supports the Novartis and International Association of Fire Fighters Campaign Against Hypertension 47964 1Lifeclinic Supports the Novartis and International Association of Fire Fighters Campaign Against Hypertension 47964 2Lifeclinic Supports the Novartis and International Association of Fire Fighters Campaign Against Hypertension 47964 3
... LATHAM, N.Y., Aug. 25 Clinicians from ... Physicians in,Latham have commenced treating cancer patients using ... VAR ), an,advancement that delivers a highly-precise image-guided,intensity-modulated ... RapidArc treatments spare healthy tissue and other ...
... Studies ... Planned, COPENHAGEN, Denmark, ... in chronic lymphocytic,leukemia and non-Hodgkin,s lymphoma., Genmab A/S (OMX: GEN) announced ... and follicular,non-Hodgkin,s lymphoma (NHL) this year., "Genmab and GSK have worked ...
Other Medicine Technology:Image Guided Radiation Therapy in Latham, NY. Now Fighting Cancer Using Fast and Precise RapidArc(TM) Radiotherapy Technology 2Image Guided Radiation Therapy in Latham, NY. Now Fighting Cancer Using Fast and Precise RapidArc(TM) Radiotherapy Technology 3Genmab Announces Upcoming Ofatumumab Studies 2Genmab Announces Upcoming Ofatumumab Studies 3Genmab Announces Upcoming Ofatumumab Studies 4
Low-profile, hand-held instrument....
Developed in conjunction with Pierce E. Scranton, Jr., M.D., the Seattle Small Joint Arthroscopy Set offers meticulously designed instrumentation for elbow, foot, and ankle surgeries....
... & Nephew ECTRA II systems permit the ... tunnel ligament endoscopically, allowing access via two ... minimizing endoscopic lens fogging with good air ... visualization and control. ECTRA knives permit the ...
Micro instruments designed to provide maximum grasping, resecting capability, and excellent maneuverability for easy access to tight, small joints (wrist, elbow, and ankle).,Features pinless hinge d...
Medicine Products: